Blog Posts by Tag: Laboratory
The Value of Payor-Specific Appeals Automation
Clarisa BlattnerSenior Director MDx Support Services, XIFIN Scott BurkClient Success Manager, XIFIN The growing number of appeals and the high costs associated with them is a challenge for many laboratories and diagnostic providers. These costs are exacerbated if the...
Lab Week 2021: Reflection and Gratitude
Once again, Lab week is upon us. As the second year celebrating Medical Laboratory Professionals Week (MLPW) in the midst of a global pandemic, it’s worth taking a moment to celebrate all our lab professionals and pathologists. Diagnostics is such a vital piece of the healthcare puzzle, and frontline laboratorians have been visible in unprecedented ways throughout the pandemic, but it is still...
On the Road to Herd Immunity, Labs and Payors Navigate Reimbursement Hurdles
Will I get paid for this? That’s not a question anyone wants to be posing when it comes to their work. Yet for most of 2020, amid the pandemic, it was one of the most pervasive questions from diagnostic laboratories to payors. While COVID-19 diagnostic testing volumes fluctuated dramatically, laboratories faced uncertainty in getting reimbursed for processing these tests. Then, in January 2021,...
Preparing for Market Disruption – Operational Lessons From COVID-19
Conor WardVP of Sales, XIFIN Joe NollarAVP LIS Product Development, XIFIN In March 2021, we had the privilege of being interviewed by Linda Wilson, Senior Editor of Medical Laboratory Observer (MLO). The discussion focused on what has been learned by laboratories during the...
The Remaining 20%: How Payor Policies and Specific Language Increase Success Rates of Appeals (Part 3)
This blog post is part three of the series. View part one. View part two. As we’ve covered statistically where our greatest challenges and opportunities lie, it’s important to recognize the appeal process is NOT a one-size-fits-all solution. Lesson 1: Report Documentation — “If it isn’t documented, it wasn’t billable” Appeals with path...
After Large Spikes in 2020, Diagnostic Laboratory Testing Volumes on the Decline
As XIFIN CEO Lâle White wrote in her recent LinkedIn article, the COVID-19 pandemic created many challenges for the diagnostic industry in 2020. In the preceding years, many laboratories were running lean with little excess capacity. With the surge in COVID-19 testing demand, labs had to quickly add capacity to handle the new testing volume. In addition, dynamic regulatory changes designed...
Temporary Claims Hold Pending Congressional Action to Extend 2% Sequester Reduction Suspension
In anticipation of possible Congressional action to extend the 2% sequester reduction suspension, CMS has instructed the Medicare Administrative Contractors (MACs) to temporarily hold all claims with dates of service on or after April 1, 2021. Per CMS’s announcement, this is intended to only take place for a short period of time and should not have any significant impact to providers’ cash flow....
How an Accurate Patient Out-of-Pocket Expense Estimator Helps Prevent Surprise Billing
There has been a lot written about surprise billing lately and the No Surprises Act, which includes surprise billing legislation, was signed into law the final week of 2020 and is slated to go into effect on Jan. 1, 2022. Surprise medical bills are unexpected balances the patient owes. This can occur for example when a patient receives care from a hospital that is in-network but is seen by a...
- 1 of 17
- next ›